Man Group PLC Shattuck Labs, Inc. Transaction History

Man Group PLC

  • $36 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$7.37 - $10.09 $585,856 - $802,074
79,492 Added 630.49%
92,100 $823,000
Q4 2023

Feb 14, 2024
BUY
$1.37 - $7.24 $17,272 - $91,281
12,608 New
12,608 $89,000
Q1 2023

May 15, 2023
BUY
$2.5 - $4.72 $35,702 - $67,406
14,281 New
14,281 $41,000
Q3 2022

Nov 14, 2022
BUY
$2.6 - $5.52 $9,258 - $19,656
3,561 Added 23.01%
19,038 $51,000
Q2 2022

Aug 15, 2022
BUY
$2.7 - $4.59 $41,787 - $71,039
15,477 New
15,477 $63,000

Others Institutions Holding STTK

# of Institutions
80
Shares Held
28.8M
Call Options Held
300
Put Options Held
1.2K
View Full List

About Shattuck Labs, Inc.

STTK Quotes by TradingView
  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $46.6M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email